PMD Psychemedics Corp: Net earnings per share for the last four quarters

Official company branding of Psychemedics Corp. (PMD)

The annual growth of basic net income per share (TTM) on the GURU.Markets terminal chart demonstrates yield dynamics, where the value of -88.30 characterizes this level. Psychemedics dominates the hair analysis segment, offering benchmark diagnostic accuracy per quarter. Government contracts and telemedicine provide positive momentum, although laboratory underutilization has temporarily reduced margins due to rising unit costs.

PMD - Psychemedics Corporation Earnings per share for the last twelve months over the range 02/11/2024 - 02/20/2024
Core merchandise of Psychemedics

This metric reflects the trailing twelve-month (TTM) net income per share, neutralizing short-term fluctuations in quarterly reporting. It measures the business's ability to scale profitability relative to operating expenses. For Psychemedics (PMD), the absence of debt and the stability of the laboratory segment make this indicator a reflection of real capital efficiency. By analyzing the 12-month YoY EPS growth chart on GURU.Markets, an investor can assess earnings sustainability without the risk of overleverage.

Competitor analysis for Psychemedics

Net earnings per share for the last four quarters agilent.com A|Quest Diagnostics Incorporated (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cologuard|Revvity Corp - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Bio-Rad Laboratories (BIO)|Net earnings per share for the last four quarters anbio.com|Sotera Health - Net earnings per share for the last 12 months|Quidel Corporation (QDEL) - Net earnings per one share for the last twelve months|OPKO Corp - Net earnings per share (EPS TTM)|CareDx, Inc (CDNA) - Net earnings per share for the last 12 months|MRVI: Net earnings per share (EPS TTM)|fulgentgenetics.com - Earnings per share for the trailing year|LAB (Standard BioTools) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytek Biosciences Inc CTKB|Earnings per share for the last twelve months OraSure Technologies Inc (OSUR)|Net earnings per share for the last 12 months exagen.com XGN|Net earnings per share (EPS TTM) MDXH (MDxHealth SA)|luciddx.com (LUCD) - Net earnings per one share for the last twelve months|Prenetics Global Ltd - Net earnings per share (EPS TTM)|IMDX (Insight Molecular Diagnostics) - Earnings per share for the last 12 months|TRIB: Net earnings per share (EPS TTM)|PRPH - Net earnings per share for the last four quarters|AIMD (Ainos, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months codiagnostics.com (CODX)|Earnings per share for the last twelve months HeartSciences (HSCS)|Net earnings per share for the last four quarters Biomerica Inc.|Earnings per share for the last twelve months Cardio Diagnostics Holdings CDIO|ONCO (Onconetix Corporation) - Earnings per one share for the last 12 months|VRAX - Earnings per share for the last twelve months|bluejaydx.com (BJDX) - Net earnings per share for the last 12 months|AWH: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months AXDX|Earnings per share for the last twelve months CENTOGENE|Net earnings per share for the last 12 months Enzo (ENZ)|Net earnings per share (EPS TTM) FRES|GENE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) ME (23andMe)